The topoisomerase I gene from Candida albicans

被引:23
作者
Jiang, WD
Gerhold, D
Kmiec, EB
Hauser, M
Becker, JM
Koltin, Y
机构
[1] CHEMGEN PHARMACEUT INC,CAMBRIDGE,MA 02139
[2] THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,DEPT PHARMACOL,PHILADELPHIA,PA 19107
[3] UNIV TENNESSEE,DEPT MICROBIOL,KNOXVILLE,TN 37996
[4] UNIV TENNESSEE,PROGRAM CELLULAR MOL & DEV BIOL,KNOXVILLE,TN 37996
来源
MICROBIOLOGY-UK | 1997年 / 143卷
关键词
Candida albicans; TOP1; null mutant; virulence;
D O I
10.1099/00221287-143-2-377
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We report here the cloning of the Candida albicans genomic topoisomerase I gene (TOP1) by use of PCR and subsequent hybridization. The predicted protein sequence shared 58.8 % identity with the Saccharomyces cerevisiae topoisomerase I and 30-50 % identity with other eukaryotic topoisomerase I proteins. A conditional gene disruption strain (CWJ477) was constructed so that one copy of TOP1 was deleted and the other copy of TOPI was placed under a regulatable promoter. Under repressed conditions, cells grew slowly and cell morphology was abnormal. The virulence of CWJ477 was markedly reduced in a mouse model system, and that of the single gene knockout strain was slightly attenuated, indicating that TOP1 might play a role in the infection of C. albicans in mice in a dose-dependent manner. Despite the reduced virulence of both the single and double knockout strains, viable cells of the pathogen were recovered from the kidneys as late as 22 d post-infection.
引用
收藏
页码:377 / 386
页数:10
相关论文
共 18 条
[1]   REDUCED VIRULENCE OF CANDIDA-ALBICANS MUTANTS AFFECTED IN MULTIDRUG-RESISTANCE [J].
BECKER, JM ;
HENRY, LK ;
JIANG, WD ;
KOLTIN, Y .
INFECTION AND IMMUNITY, 1995, 63 (11) :4515-4518
[2]   ATTENUATED VIRULENCE OF CHITIN-DEFICIENT MUTANTS OF CANDIDA-ALBICANS [J].
BULAWA, CE ;
MILLER, DW ;
HENRY, LK ;
BECKER, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10570-10574
[3]   DNA TOPOISOMERASES - ESSENTIAL ENZYMES AND LETHAL TARGETS [J].
CHEN, AY ;
LIU, LF .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1994, 34 :191-218
[4]   MITOTIC RECOMBINATION IN THE RDNA OF S-CEREVISIAE IS SUPPRESSED BY THE COMBINED ACTION OF DNA TOPOISOMERASES-I AND TOPOISOMERASES-II [J].
CHRISTMAN, MF ;
DIETRICH, FS ;
FINK, GR .
CELL, 1988, 55 (03) :413-425
[5]  
FONZI WA, 1993, GENETICS, V134, P717
[6]   IDENTIFICATION OF THE AMINOCATECHOL A-3253 AS AN IN-VITRO POISON OF DNA TOPOISOMERASE-I FROM CANDIDA-ALBICANS [J].
FOSTEL, J ;
MONTGOMERY, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) :586-592
[7]   CHARACTERIZATION OF DNA TOPOISOMERASE-I FROM CANDIDA-ALBICANS AS A TARGET FOR DRUG DISCOVERY [J].
FOSTEL, JM ;
MONTGOMERY, DA ;
SHEN, LL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (10) :2131-2138
[8]   THE TOPOISOMERASE-I GENE FROM USTILAGO-MAYDIS - SEQUENCE, DISRUPTION AND MUTANT PHENOTYPE [J].
GERHOLD, D ;
THIYAGARAJAN, M ;
KMIEC, EB .
NUCLEIC ACIDS RESEARCH, 1994, 22 (18) :3773-3778
[10]   PATHOGENICITY OF CANDIDA-ALBICANS AUXOTROPHIC MUTANTS IN EXPERIMENTAL INFECTIONS [J].
KIRSCH, DR ;
WHITNEY, RR .
INFECTION AND IMMUNITY, 1991, 59 (09) :3297-3300